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Abstract
Contagious bovine pleuropneumonia is a severe respiratory disease of cattle that is caused by a bacterium of the
Mycoplasma genus, namely Mycoplasma mycoides subsp. mycoides (Mmm). In the absence of classical virulence
determinants, the pathogenicity of Mmm is thought to rely on intrinsic metabolic functions and specific components of the
outer cell surface. One of these latter, the capsular polysaccharide galactan has been notably demonstrated to play a role in
Mmm persistence and dissemination. The free exopolysaccharides (EPS), also produced by Mmm and shown to circulate in
the blood stream of infected cattle, have received little attention so far. Indeed, their characterization has been hindered by
the presence of polysaccharide contaminants in the complex mycoplasma culture medium. In this study, we developed a
method to produce large quantities of EPS by transfer of mycoplasma cells from their complex broth to a chemically defined
medium and subsequent purification. NMR analyses revealed that the purified, free EPS had an identical b(12.6)-
galactofuranosyl structure to that of capsular galactan. We then analyzed intraclonal Mmm variants that produce opaque/
translucent colonies on agar. First, we demonstrated that colony opacity was related to the production of a capsule, as
observed by electron microscopy. We then compared the EPS extracts and showed that the non-capsulated, translucent
colony variants produced higher amounts of free EPS than the capsulated, opaque colony variants. This phenotypic
variation was associated with an antigenic variation of a specific glucose phosphotransferase permease. Finally, we
conducted in silico analyses of candidate polysaccharide biosynthetic pathways in order to decipher the potential link
between glucose phosphotransferase permease activity and attachment/release of galactan. The co-existence of variants
producing alternative forms of galactan (capsular versus free extracellular galactan) and associated with an antigenic switch
constitutes a finely tuned mechanism that may be involved in virulence.
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Introduction
Bacteria of the Mycoplasma genus have evolved from their
Gram-positive ancestors by massive reduction of their genome
size. They are considered the smallest and simplest self-replicating
organisms, with many missing biosynthetic pathways and the
notable absence of a cell wall [1]. Despite this apparent simplicity,
mycoplasmas are able to develop metabolic responses and
adaptations similar to those of more complex bacteria, due
notably to their higher proportion of multifunctional enzymes [2].
Several mycoplasma species are known to cause important diseases
in humans and animals. Members of the so-called Mycoplasma
mycoides cluster are particularly deleterious for ruminants and are
responsible for severe economic losses worldwide. Mycoplasma (M.)
mycoides subsp. mycoides (Mmm) is the causal agent of contagious
bovine pleuropneumonia (CBPP), a highly contagious respiratory
disease notifiable to the World Organization for Animal Health
(Office International des Epizooties, OIE). CBPP was formerly one
of the major cattle diseases worldwide and has now been
eradicated from many countries, although it persists in Africa.
Under natural conditions, CBPP affects only the Bos genus,
producing pathognomonic clinical lesions confined to the thoracic
cavity [3]. Contrary to other mycoplasmas involved in cattle
respiratory diseases, such as M. bovis [4], Mmm is not considered an
agent of co-infection and is often isolated on its own. This clinical
picture contrasts with that observed in infections by M. mycoides
subsp. capri, its closest phylogenetic neighbor and one of the agents
of contagious agalactia, a small-ruminant syndrome affecting
diverse organs (udder, joints, eyes, lungs).
None of the usual virulence determinants described for other
bacteria, such as toxins, invasins or cytolysins, has been identified
in the currently sequenced Mmm genomes [5,6]. However, several
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mechanisms have been proposed to account for Mmm pathoge-
nicity such as adherence to the host tissues, immune evasion,
persistence, dissemination, inflammation and cytotoxicity [7]. The
polysaccharides have been often implicated in the pathogenesis of
bacteria colonizing the lung [8] and have attracted attention for
decades as a potential Mmm virulence factor. Mmm has been shown
to produce two types of polysaccharides: a capsular one, namely
galactan, identified [9] and chemically characterized [10] by
Buttery and Plackett in the 1960s, and an extracellular one,
hereafter named exopolysaccharide (EPS) as defined by Branda
and collaborators [11]. The purification of free EPS has been
jeopardized by polysaccharide contaminants in the complex
culture medium used to grow mycoplasmas. EPS is immunolog-
ically related to the capsular galactan and has been found in large
amounts as a free Mmm product unassociated with cells, both in
culture supernatants and in the blood of infected cattle [12]. Mmm
strains able to produce large amounts of capsular polysaccharide
proved less sensitive to growth inhibition by bovine antisera [13]
and displayed longer bacteremia than strains with little capsular
polysaccharide in a mouse infection model [14]. This clearly
pointed towards a role of capsular polysaccharides in Mmm
persistence and dissemination. Antigenic cross-reactivity between
Mmm capsular galactan and the pneumogalactan isolated from
bovine lung was proposed to be at the origin of autoimmune
reactions [15] and thus to participate in the inflammation process.
In addition, intravenous injection of free, extracellular EPS
induced specific effects on the vascular system of the lung and
respiratory system of cattle [16] and promoted persistent
bacteremia in calves, when it preceded inoculation of an Mmm
strain [17,18].
The present study was conducted to elucidate the composition
and structure of the EPS produced by Mmm and to compare it
with the capsular galactan. We developed a purification method
consisting of transferring mycoplasma cells from their complex
growth medium to a chemically defined medium to minimize
polysaccharide contamination. Two strains were used: (i) the type
strain PG1T, for which the complete genome sequence is available
[5], and (ii) the field strain Afade´, highly virulent and already used
for biofilm formation [19] and virulence studies [20], as it causes
CBPP under natural and experimental conditions [21]. EPS
purified from the supernatant of Mmm strain Afade´ proved to have
the same composition and structure as capsular galactan and was
also recognized by CBPP-convalescent bovine serum. Further-
more, the production of capsular versus free galactan was
associated with variations in colony opacity related to an antigenic
switch of a specific glucose permease. In silico analyses were
conducted in order to decipher the metabolic pathways that might
account for the production of either capsular galactan or free EPS
by the corresponding opaque and translucent variants.
Materials and Methods
1. Strains, Variant Selection and Growth Conditions
Two strains were used in this study: Mmm Afade´ (From the
CIRAD collection, isolated from cattle in Chad in 1968), used for
EPS purification and for selection of opaque (OP) and translucent
(TR) colony variants and PG1T (type strain, NCTC 10114), used
for electron microscopy and for in silico analysis of galactan
biosynthetic pathways. Both strains were grown at 37uC under 5%
CO2 in PPLO-based medium (DIFCO) supplemented as de-
scribed previously [22]. The chemically defined CMRL-1066
medium (Invitrogen), supplemented with amoxicillin 2 g/L
(GlaxoSmithKline), was used for exopolysaccharide production.
OP and TR colony variants of strain Afade´ were selected on
PPLO agar medium and sub-cultured to check their homogeneity.
They were also grown on 30 mg/ml Congo red plates to visualize
any extracellular material. OP and TR colonies were analyzed by
colony blotting as described previously [23]. In brief, the
monoclonal antibody 3F3 [24] was used to detect TR colonies,
while OP colonies were counterstained with Ponceau red. The
proportion of each variant was estimated by colony counting after
blot staining.
2. EPS Production and Purification
Fifty mL of PPLO-based medium were inoculated with 500 mL
of mycoplasma culture in stationary phase and incubated for
2 days at 37uC in 5% CO2. Mycoplasma cell density was
estimated by cell enumeration using the most probable number
method [25]. Cells were harvested by centrifugation at 12000 g for
45 min at 20uC, washed once with 20 mL sterile PBS (10 mM
sodium phosphate, 150 mM NaCl, pH 7.4) and finally suspended
in 500 mL sterile PBS. This suspension was used to inoculate
PPLO-based broth or CMRL-1066 medium with 108–1010
mycoplasmas/mL. The cultures were further incubated for 72 h
to 96 h. Aliquots were sampled at 24 h intervals to measure pH
and cell density and to purify EPS.
EPS were purified as described by De Vuyst et al. [26], with
a few modifications. Cells were removed by centrifugation
(14000 g, 45 min, 4uC). A proteinase K (Promega) treatment
(60 mg/mL for 4 hours at 37uC) was applied only as an
extraction control from the PPLO-based medium in order to
degrade serum proteins associated with EPS. Polypeptides were
precipitated with 1/10 volume of cold 100% (w/v) trichlor-
oacetic acid (Sigma-Aldrich) at 4uC for 2 hours followed by
centrifugation (14000 g, 60 min, 4uC). Polysaccharides con-
tained in the supernatant were precipitated with 6 to 10
volumes of cold acetone at 220uC for 48 h and collected after
centrifugation at 14000 g, 60 min at 4uC. The acetone was
carefully removed and the pellet was air-dried and dissolved in
ultra-pure sterile water. For NMR and monomer composition
analysis, extracts were dialyzed against regularly-renewed ultra-
pure sterile water for 48 hours at room temperature in 3.5 kDa
cut-off dialysis tubing (Spectrum Laboratories).
The effect of carbon sources on EPS production by strain Afade´
was studied by adding to CMRL-1066 medium, which already
contains 1 g/L glucose, either (i) 4 g/L glucose, mannitol,
galactose, sorbitol or sucrose before seeding or (ii) 1 g/L glucose
at 24, 48 and 72 hours after seeding. Carbohydrates were
prepared as 200 g/L stock solutions and sterilized by filtration
(0.22 mm filter units) before addition to CMRL-1066.
3. EPS Quantification and Characterization
The concentration of total sugars was estimated by phenol/
sulfuric acid method [27] using glucose as standard. For each
sample, the determination was done in triplicate and results were
expressed as mg of glucose/mL of CMRL-1066 mean +/2
standard deviation (SD). The potential presence of polypeptides
in the EPS extract was assessed by silver staining of Any kD
polyacrylamide gel (Bio-Rad) using the proteosilver kit from
Sigma-Aldrich.
EPS was detected with a polysaccharide detection kit and
immunodetected by dot blotting using a CBPP positive serum. In
brief, 2mL of the EPS extract were spotted onto a nitrocellulose
membrane that was either stained with the glycoprotein detection
kit from Sigma-Aldrich or treated as previously described for dot
immunobinding [28].
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4. Electron Microscopy
Electron microscopy was performed as previously described
[29] using five-day-old colonies of Mmm strain PG1T grown on
solid PPLO-based medium. Samples were examined under a
Philips CM120 transmission electron microscope operating at an
accelerating voltage of 75 kV.
5. Monosaccharide Composition Determination
The monosaccharide components were determined by high-
performance anion exchange chromatography (HPAEC) on a
CarboPak PA 1 with a pulsed amperometric detector (Dionex ICS
3000 system). After hydrolysis of EPS (1 mg) with 4 M CF3CO2H
(100uC, 4 h), aliquots of the extract were passed through a
4650 mm Propac PA1 pre-column (Dionex) before separation of
anionic compounds on a 46250 mm Propac PA1 column
(Dionex) at 30uC. Gradient elution was performed with a multi-
step gradient as follows: 0–25 min, 90% H2O and 10% NaOH
160 mM; 25–34 min, 100% NaOH 200 mM; 35–50 min 90%
H2O and 10% NaOH 160 mM at a flow rate of 1 mL/min. Peak
analysis was performed using Chromeleon software, version 7.0.
6. NMR Spectroscopy
Prior to NMR analysis, samples were exchanged twice with
99.9% D2O (Euriso-top), dried under vacuum, and dissolved in
99.96% D2O (,1 mg/0.5 mL).
1H NMR spectra were recorded,
at 80uC, on a Bruker Avance 500 spectrometer equipped with a
5 mm BBI probe and Topspin 1.3 software. 1H NMR spectra
were accumulated using a 30u pulse angle, a recycle time of 1 s
and an acquisition time of 2 s for a spectral width of 3 000 Hz for
32 K data points with presaturation of the HOD signal using a
presaturation sequence provided by Bruker. 13C NMR experi-
ments were conducted on the same spectrometer operating at
125.48 MHz with 2 s as relaxation delay.
The 2D 1H/1H COSY, 1H/1H TOCSY, 1H/1H NOESY,
1H/13C HSQC and 1H/13C HMBC spectra were acquired with
standard pulse sequences delivered by Bruker.
7. In silico Analysis of Candidate Galactan Biosynthetic
Pathways
Genes potentially involved in EPS biosynthetic pathways were
retrieved from the molligen database [30] and from the
Carbohydrate-Active EnZymes database (CAZy) [31]. Potential
transmembrane regions were predicted by TMHMM2 [32].
Putative functions and conserved domains of proteins encoded
by genes were analyzed using the profile HMM method [33,34]
and PSI-BLAST [35].
Results and Discussion
1. Mmm Growth and EPS Secretion in Defined Medium
versus Complex Mycoplasma Broth
It had been previously shown that large amounts of polysac-
charides not bound to the cells could be recovered from Mmm
cultures [17,36]. However, at the time, these polysaccharides
could not be purified from the complex, undefined medium used
to grow mycoplasmas. In this work we developed an experimental
procedure that limits the potential contamination of newly
synthesized polysaccharides by saccharides from the growth
medium. Mycoplasma cells were first grown to stationary phase
in a classic PPLO-based medium, then washed and transferred to
a chemically defined, synthetic medium (CMRL-1066) for further
incubation. CMRL-1066 is a constituent of the commonly used
mycoplasma SP4 medium [37] and contains all the components
needed to support cellular metabolism, but not growth. Following
a 72 h-incubation in CMRL-1066, polysaccharide extracts were
clearly detected in culture supernatants of Mmm strain Afade´,
while no polysaccharides were detected in non-inoculated CMRL-
1066 used as negative control (Figure 1A). These polysaccharides
were not attached to the cells and were therefore considered as
EPS [11]. In contrast, polysaccharide production by Mmm could
not be assessed in PPLO-based medium because of detection of a
strong background in the negative control corresponding to the
saccharides contained in this growth medium (Figure 1A).
EPS production in CMRL-1066 was shown to be reproducible,
maximum after 72 h of incubation and related to the initial viable
mycoplasma titer (Figure 2, Table 1). EPS detection proved to be
difficult when CMRL-1066 was inoculated with less than 108
mycoplasmas/mL. CMRL-1066 was not able to sustain myco-
plasma growth and a decrease in the number of viable cells was
observed during the incubation period (Figure 2, Table 1). This
decrease in viability was not related to a high inoculum
concentration, as it was also evidenced in several serial ten-fold
dilutions of the initial culture (Table 1). The poor cholesterol
concentration (0.2 mg/L) and the absence of other fatty acids in
CMRL-1066 might result not only in growth inhibition but also in
cell lysis, as previously suggested [38]. In turn, it can be
hypothesized that this cellular decay may artificially contribute
to EPS release into the culture supernatant [39]. However, no
correlation was found between loss of viability and EPS
production after 72 h of incubation (data not shown), suggesting
that the contribution of cell lysis to EPS release was minor.
In 1972 Sutherland suggested that bacterial growth inhibition
may result in a rise in EPS production due to the increased
availability of EPS precursors, not used for glycolysis [40]. This
was explored here by analysis of CMRL-1066 supplementation
with different sugars during incubation. Regular addition of
glucose (1 g/L) had no effect on mycoplasma viability but resulted
in a 50% increase in EPS production (Figure 2). A similar increase
of EPS production was measured when 4 g/L of glucose were
added to CMRL-1066 at the beginning of incubation (Table 1).
This indicated that during incubation in minimal medium unable
to sustain growth, glucose was not catabolized by mycoplasmas but
was used to produce EPS. Supplementation of CMRL-1066
medium, inoculated with 109 mycoplasmas/ml, with other
carbohydrates (mannitol, galactose, sucrose or sorbitol; 4 g/L)
was also tested to measure the effect of the sugar source on EPS
Figure 1. Exopolysaccharide (EPS) secretion by Mmm strain
Afade´ in supplemented PPLO broth and CMRL-1066 medium.
EPS extracted either from Mmm culture (Afade´) or from unseeded
medium used as negative control (Neg) were spotted onto a nylon
membrane and either stained with a glycoprotein detection reagent (A)
or immunodetected using a serum from a CBPP-positive bovine (B).
doi:10.1371/journal.pone.0068373.g001
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synthesis. None of these sugars modified the viability of strain
Afade´ after 72 h of incubation (Table 1). As expected, the addition
of sorbitol, which is not used as an energy source [41] or
exploitable for EPS biosynthesis (due to absence of the required
metabolic pathways) had no effect. Mannitol and sucrose
supplements resulted in increased EPS production. This could
be due to the more efficient transport and recycling of these two
sugars into EPS, in comparison with glucose.
2. Structural Determination and Immunogenic Properties
of Free EPS Secreted by Mmm
Mmm EPS was subjected to total acid hydrolysis with 4 M
trifluoroacetic acid. HPAEC-PAD analysis of the acid hydrolysate
revealed the presence of galactose (96.761.0%) and glucose
(3.361.0%). This composition is similar to that described by
Plackett et al. for the galactan Mmm capsule [36]. The structural
analysis of Mmm EPS was carried out by 1H and 13C NMR
spectroscopy. The 7 resonances observed on the 1H NMR
spectrum (Figure 3A) and correlations detected on the 2D NMR
COSY spectrum (Figure 3B) led us to attribute the observed
chemical shifts to protons of galactosyl residues: 5.046 (H-1), 4.118
(H-2), 4.068 (H-3), 4.013 (H-4), 3.965 (H-5), 3.864 (H-6) and 3.648
(H-69) ppm. On the 2D NMR HSQC spectrum (Figure 3C), the
connectivities observed between H-1 and C-1 (109.0 ppm), H-2/
C-2 (82.1 ppm), H-3/C-3 (78.0 ppm), H-4/C-4 (84.5 ppm), H-5/
C-5 (70.8 ppm) and H-6,H-69/C-6 (70.2 ppm) were characteristic
of a galactan homopolymer. The 13C signal at 109.0 ppm and 1H
signal at 5.046 ppm were typical of D-galactose residues with a b
furanoside configuration [42]. Chemical shift values obtained for
C-6 indicated the presence of a linkage on the C-6 in Gal residues.
The 1H/1H NOESY spectrum presented interesting inter-residue
connectivities: H-1 of galactose (d 5.046) was connected to two
signals at d 3.864 and 3.648 belonging to H-6 and H-69 of
galactose. This correlation was confirmed on the 1H/13C HMBC
spectrum. Thus, these connectivities and 1H and 13C chemical
shifts are consistent with the literature values for a b(12.6)-
galactofuranose polymer [43]. Again, the structure of the EPS
released into the culture medium was identical to that of the
capsular galactan [10]. Previous studies had reported galactan to
be immunogenic [12]. The EPS produced in our experimental set
up was also detected by serum from a CBPP-convalescent bovine
(Figure 1B). This did not represent a cross-reaction due to protein
contamination of the EPS extract, since no polypeptides were
detected by silver staining after SDS PAGE (data not shown).
3. Correlation between EPS Production and Colony
Appearance
In this study we showed that the free galactan secreted by Mmm
strain Afade´ presented the same monomeric composition and
structure as the capsular polysaccharide previously described,
which was associated with Mmm strain V5 cells [10,36]. In other
bacteria the presence of a polysaccharidic capsule has often been
associated with an opaque colony phenotype [29,44,45]. Variation
in colony opacity has also been described in mycoplasmas (i.e. M.
pulmonis [46] and M. hyorhinis [47]) but not in Mmm. However,
Minga reported the existence of rough and smooth morphotypes
of Mmm colonies and showed that they were related both to the
capacity to produce a capsule and to pathogenicity [48]. Here we
showed that both Mmm strains PG1T and Afade´ produced a
mixture of opaque (OP) and translucent (TR) colonies on agar
(Figure 4A). TR colonies showed the typical ‘‘fried egg’’
appearance, with a small opaque center surrounded by a large
translucent peripheral area. In contrast, OP colonies were darker
and their center was not always distinct from the peripheral area.
When grown on agar plates containing Congo red, a direct dye
known to interact with the extracellular matrix, OP colonies
showed an intense and uniform red coloration, while TR colonies
were poorly stained, with staining limited mainly to their center
(Figure 4A). OP and TR variants of Mmm PG1T were then
observed by electron microscopy following staining with Ruthe-
nium red, which binds to polysaccharides. Electron micrographs
obtained from TR colonies showed separated cells with scanty
extracellular material, while cells from OP colonies were
aggregated and coated with a patchy, electron-dense material
made of polysaccharides (Figure 4B), which appeared to attach the
cells together. This cellular aggregation may account for the
colony opacity, as previously suggested for Nesseria gonorrhoeae [49].
Interestingly, OP and TR colony variants differed in their
capacity to secrete EPS, with the TR yielding three-fold more EPS
than the OP variant (Table 1, Figure 5). Viability in CMRL-1066
was comparable for both colony variants, though acidification of
the culture medium was more pronounced for the TR variant,
indicating that glycolysis was more efficient (Figure 5). Glucose
metabolism is largely dependent on the capacity to import sugars
and, in a previous study, we had demonstrated that a glucose
permease (MSC_0860/0873), belonging to the phosphoenolpyr-
uvate phosphotransferase system (PTS), of Mmm PG1T was
regulated by a genetic ON/OFF switch that resulted in premature
termination of the PTS permease and epitope variation [23]. The
monoclonal antibody targeting this epitope, namely 3F3, was
shown to bind to TR but not to OP colonies (Figure 6). This may
suggest that truncation of the glucose PTS permease in OP
variants results in less efficient glucose transport and, consequent-
ly, less efficient glycolysis and EPS synthesis.
Figure 2. Kinetics of exopolysaccharides secretion and viability
of Mmm strain Afade´ following transfer into CMRL-1066
medium with (red) or without (blue) glucose supplementation.
Glucose (1 g/L) was added at 24, 48 and 72 h (arrows).
doi:10.1371/journal.pone.0068373.g002
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The frequency of reversion from 3F3-negative (3F3NEG) to
3F3-positive (3F3POS) variants of strain Afade´ was shown to vary
from 1026 to 1022 [23]. In the present study, this reversion
resulted in less than 0.2% of 3F3NEG (OP colony variant) in
3F3POS cells (TR colony variant) or in Mmm strain Afade´
cultures, and a proportion of 1 to 5% of 3F3POS (TR colony
variant) cells in 3F3NEG (OP colony variant) cultures at the time
of transfer into CMRL-1066 medium. This may account for the
weak EPS production obtained from the OP (3F3NEG) colony
variant. We then attempted to minimize the proportion of TR
(3F3POS) cells in OP (3F3NEG) cultures in order to assess EPS
production by the OP colony (3F3NEG) variant cells. Several
cultures were tested and the one with the lowest titer of 3F3POS
(TR colony variant) cells (i.e. 0.5%) was used to inoculate CMRL-
1066 medium. Under these conditions, EPS production was very
low, whatever the sugar source (Table 1). However, addition of
different sugars to the CMRL-1066 medium appeared to
modulate the level of reversion to 3F3POS (TR colony variant)
after 72 hours of incubation. Mannitol was the only carbohydrate
which led to an increase of 3F3POS (TR colony variant), from
0.5% to 12%, but the EPS release was not enhanced, due to
considerable cell decay. This suggests the existence of complex
regulations for transport and catabolism of the different sugars.
4. In silico Analysis of Candidate Galactan Biosynthetic
Pathways
We showed that TR colony variants, which were detected by
3F3 monoclonal antibody, produced free, extracellular galactan.
In contrast, OP colony variants, which did not display any
reaction with the 3F3 antibody, because of a premature
termination of their glucose PTS permease, produced capsular
galactan. Polysaccharide biosynthesis by OP colony variants was
intriguing, since truncation of the glucose PTS permease would be
expected to result in an overall less efficient glucose transport and
therefore hampering notably of polysaccharide synthesis.
We tried to decipher the biochemical links between glucose
intake, polysaccharide chain elongation and attachment/release of
the galactan by retrieving in silico all potentially involved Mmm
genes. The genomes of the 2 currently sequenced Mmm strains,
namely PG1T (accession number NC_005364.2) [5] and Gladys-
dale (accession number CP002107.1) [6], were used.
As NMR analyses revealed that galactan is composed of
galactose residues in the furanose ring form, we first looked for
enzymes involved in UDP-galactofuranose synthesis, which is the
usual precursor of a galactofuranose polymer. UDP-galactofur-
anose is usually formed from UDP-galactopyranose after the
action of an UDP galactofuranose mutase Glf [50,51]. One glf
gene identified in Mmm strain PG1T [5] is also present in the
Gladysdale genome. In bacteria, UDP-galactopyranose can be
synthesized via two enzymes of the Leloir pathways [52], either
from galactose-1-phosphate after the action of a galactose-1-
phosphate uridylyltransferase (GalT) or from UDP-glucose via an
UDP-glucose 4-epimerase (GalE). No galT homologue was
retrieved from the genomes of Mmm, indicating that galactose is
not a source for galactan synthesis. This is concordant with our
experiment showing that galactose was unable to enhance galactan
synthesis (Table 1). In contrast the glucose-dependent synthetic
pathway is highly probable since two genes were identified in both
genomes, one of which encodes for UDP-glucose 4-epimerase
Table 1. Exopolysaccharide secretion and viability of Mmm strain Afade´ in CMRL-1066 medium at the time of inoculation (T0) and
after 72 h of incubation (T72).
CFU/mL
Strain/variant Sugar added (4 g/L) T0 T72 EPS mg/mL T72
Afade´ None 4.861010 4.06108 48.8
None a(3.6+/21.0)x109 a(2.1+/21.0)x108 a25.2+/23.0
None a(4.9+/20.8)x108 a(8.9+/27.0)x106 a8.2+/24.4
None a(4.0+/20.5)x107 a(1.4+/20.2)x105 a1.0+/20.5
None 4.86106 4.06104 0.5
None 4.86105 3.06101 0.6
None 6.56109 1.76106 24.0
Glucose 6.56109 2.56106 31.8
Sorbitol 6.56109 6.56105 27.9
Mannitol 6.56109 1.76107 37.0
Galactose 6.56109 8.56106 28.5
Sucrose 6.56109 4.06107 37.5
TR variant None a(3.4+/20.5)6108 a(6.1+/25.3)6106 a15.4+/21.1
OP variant None a(6.0+/22.0)6108 a(2.7+/20.6)6108 a2.9+/21.0
None 6.56108 1.26108 0.7
Glucose 6.56108 8.56107 2.3
Sorbitol 6.56108 1.26108 0.5
Mannitol 6.56108 4.06105 0.9
Galactose 6.56108 2.06107 0.7
Sucrose 6.56108 1.26108 1.9
aData correspond to mean +/2 standard deviation of several (.= 3) experiments.
doi:10.1371/journal.pone.0068373.t001
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(GalE) and the other for a glucose-1-phosphate uridylyltransferase
(GalU) that uses glucose-1-phosphate to generate UDP-glucose.
Glucose intake in Mmm certainly relies on two similar (47%)
glucose PTS permeases (MSC_0054 and MSC_0860/873) that
have been identified in strain PG1T [23] and are also present in
the Gladysdale strain. The PTS glucose permeases usually allow
the concomitant uptake and phosphorylation of glucose into
glucose-6-phosphate [53], the typical precursor of glycolysis. The
probability that glucose intake might be mediated by other generic
permeases, such as ABC transporter, is low since it would require
further activation of glucose by phosphorylation that is impaired
because of the mutation of the two glucokinase genes in PG1T
[23]. Entry into the galactan biosynthetic pathway further requires
the isomerization of glucose-6-phosphate to glucose-1-phosphate,
which is most probably achieved by the phosphoglucomutase
(ManB) predicted in Mmm (MSC_0829, [5]). It has been shown
recently in Vibrio cholerae that glucose PTS permeases are general
regulators of genes involved in EPS synthesis [54]. In our model,
we hypothesize that MSC_0860/873 might play a role in the
regulation of the attachment/release of galactan, its impairment in
OP variants resulting in a constitutive attachment of the galactan.
Three predicted glycosyltransferases (GT), cps (MSC_0109),
EpsG (MSC_0108) and MSC_0771 previously identified in the
Mmm PG1T genome [5] are good candidates for elongation of the
galactan chain from the UDP-galactofuranose precursor.
MSC_0109 (cps) showed 45% and 42% similarity with glycolipid
synthases described in M. genitalium [55] and M. pneumoniae [56],
respectively. In Mycoplasmas, glycolipid synthases are able to
transfer galactosyl and glucosyl residues to membrane-bound
diacylglycerol [57]. Therefore, MSC_0109 is a good candidate for
galactan attachment to the cytoplasmic membrane. This was
supported by preliminary northern blot experiments that showed a
differential expression of the cps gene in capsulated versus non-
capsulated colony variants (Figure S1).
Functional prediction of EpsG using HHPred [34] and Phyre2
[33] revealed a structure that was highly similar (e-value = 3.4e-38,
probability 100%) to that of the cellulose synthase BcsA of
Rhodobacter sphaeroides [58]. Synthases are membrane-embedded
glycosyltransferases involved in polymer formation and transloca-
Figure 3. NMR spectra of EPS produced by Mmm. A: 1H NMR spectrum, B: 2D COSY NMR spectrum and C: 2D HSQC NMR spectrum.
doi:10.1371/journal.pone.0068373.g003
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tion across the cytoplasmic membrane [59]. Four potential
transmembrane regions were predicted by TMHMM2 [32] for
EpsG, with a large cytoplasmic loop (36–312) (Figure S2) which
showed homology with family 2 glycosyltranferases (http://www.
cazy.org, [31]), a group of GT known to add sugars in the b-
configuration which is in agreement with the galactan structure.
Two conserved motifs (DXD and QxxRW), which are common
markers of processive enzymes in various bacterial models [60],
were found in the cytoplasmic loop (Figure S2). Further structural
analysis showed that the cytoplasmic domain was similar (e-
value = 2.8e-26, probability 99.93%) to the UDP-galactofuranosyl
glycotransferase GlfT of Mycobacterium turberculosis [61]. We
therefore hypothesized that EpsG is a putative galactan synthase
which could catalyze the polymerization of b-1,6-linked galacto-
furanose and facilitate its export across the cytoplasmic mem-
brane. Furthermore, synthase-dependent exopolysaccharide secre-
tion was shown to occur in the presence or absence of a lipid
acceptor molecule [59]. In our model, synthase-dependent
galactan synthesis might be active whether galactan is attached
to a glycolipid anchor, or not.
The third predicted GT, MSC_0771, was not related to any of
the 90 GT families described so far. Structural analysis revealed
two domains of which only the N-terminal one (1–199) was similar
to diverse bacterial and eukaryotic glycosyltransferases. Its role in
galactan biosynthesis remains hypothetical.
In conclusion, this in silico analysis points toward i) a synthase-
dependent pathway for galactan synthesis, ii) a putative role of
MSC_0109 in attachment of galactan to the membrane and iii) a
potential regulation of this attachment by glucose PTS permease.
However detailed functional studies are now needed to unravel the
precise roles of each GT and the genetic basis and triggering
conditions underlying the switch between capsule production (OP
colony variants) and EPS secretion (TR colony variants).
Conclusions
We have developed a simple method for the purification of
Mmm EPS. The incubation of washed mycoplasma cells in a
completely defined medium, able to support cellular metabolism,
allowed EPS synthesis for at least 72 hours, while preventing
contamination with polysaccharides from the culture medium.
Preliminary results in our laboratory indicate that this method is
suitable for use in other mycoplasmas.
This method was applied to characterize the free EPS secreted
by Mmm. Purified EPS had an identical b(12.6)-galactofuranosyl
structure to that of Mmm capsular galactan. The presence of OP
and TR colony variants in Mmm cultures, which varied greatly in
Figure 4. PG1T colony opacity is related to the presence of capsular material. A: Colony morphology of PG1T opaque (OP) and translucent
(TR) colony variants grown on PPLO supplemented agar with (right) or without (left) Congo red. Magnification: x30. B: Electron microscopy of
Ruthenium red-stained PG1T OP and TR colonies. CM: cytoplasmic membrane.
doi:10.1371/journal.pone.0068373.g004
Figure 5. Growth, pH and exopolysaccharide (EPS) secretion of
translucent (blue) and opaque (red) colony variants in CMRL-
1066 medium. 50 ml of CMRL-1066 medium were inoculated with
108–109 CFU/mL and incubated for 96 hours. Viable titer, pH and EPS
production were determined every 24 h.
doi:10.1371/journal.pone.0068373.g005
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their capacity to produce free EPS, was observed. Both variants
appeared to be able to synthesize polysaccharides. However, these
polysaccharides either remained attached to the cells, constituting
a capsule (opaque colony variants), or were released into the
culture medium as free EPS (translucent colony variants). We
finally conducted in silico analyses of Mmm genes potentially
involved in polysaccharide biosynthesis and proposed candidate
pathways that might account for the alternative production of
capsular versus free galactan by the corresponding opaque and
translucent colony variants.
In Streptococcus pneumoniae spontaneous phase variation between
opaque and translucent colony variants has been associated with
diverse levels of virulence at different stages of the disease, from
invasion to transmission [62]. It remains to be elucidated whether
variations in the production of capsular versus free galactan can
regulate Mmm pathogenicity and how. Although free galactan has
been found in the body fluids and urine of infected animals
[12,63], the occurrence and proportion of EPS versus capsule-
producing variants in vivo has yet to be determined. This would
constitute a key step in the understanding of Mmm pathogenicity,
since the emergence of sub-populations in a given ecological niche
is known to lead to bacterial persistence.
Supporting Information
Figure S1 Northern blot hybridization of total RNA of the
opaque (OP) and translucent (TR) colony variants of Mmm strain
Afade´ with a cps (MSC_0109) or rDNA 16S probe. Total RNA
extraction and northern blot hybridization was performed as
previously described [1]. The rDNA 16S probe was obtained by
PCR [2]. Transcription of the rDNA 16S was used to normalize
the hybridization. The cps gene probe was obtained by PCR with
specific primers (59 TGATGGATCAACAGATAACACCA 39
and 59 TTTGGGCGTGAGTATCAATAAG 39).
(DOC)
Figure S2 Schematic representation of the predicted membrane
topology of Mmm EpsG (MSC_0108) glycosyltransferase. Numbers
indicate the localization of transmembrane helices. DxD (red) and
RxxQW (blue) motifs are showed.
(TIF)
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